CHEN Yao, XU Guo-liang, LI Bing-tao, et al. Effect of Gegen Qinlian Tang Serum in Regulating Glucose Metabolism of IR-HepG2 Cells[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(10): 156-160.
CHEN Yao, XU Guo-liang, LI Bing-tao, et al. Effect of Gegen Qinlian Tang Serum in Regulating Glucose Metabolism of IR-HepG2 Cells[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(10): 156-160. DOI: 10.13422/j.cnki.syfjx.20180836.
Objective: To explore the regulatory effect of Gegen Qinlian Tang serum on the glucose metabolism of insulin resistance (IR) HepG2 (IR-HepG2). Method: Normal HepG2 cells were taken as blank control group. IR-HepG2 cells were divided into model group
fenofibrate group
low and high-dose Gegen Qinlian Tang group. With glucose consumption as the pharmacodynamic index
LC-MS was used for the analysis of metabolites of IR-HepG2 cells and IR-HepG2 cells. Mass Profiler Professional (MPP) software was used to analyze the data to obtain biomarkers; after validation
the relationship between glucose consumption and biomarkers was studied. Result: Three biomarkers were found to be dose dependent and could regulate glucose metabolism. Conclusion: Gegen Qinlian Tang-containing serum could regulate the content of tryptophan
pantothenic acid and adenine in IR-HepG2 cell to reduce sugar metabolism.